ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy

NEXT STORY
ALRT Diabetes Solution Complements President Trump’s Initiative to Lower Insulin Costs and Drive Better Diabetes Care
PREV STORY
Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

author_avatar
NASDAQ Market News

LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients

author_avatar
NASDAQ Market News

Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors

TEL AVIV, Israel, March 02, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), ...

author_avatar
NASDAQ Market News